Rajput, Sandeep <br/><br/>
TLR4 is a novel determinant of the response to paclitaxel in breast cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2013 
 - 1676-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-1019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis Regulatory Proteins--genetics<br/>Autocrine Communication<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression<br/>Humans<br/>Mice<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Paclitaxel--pharmacology<br/>Phosphorylation<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Receptors, Cytokine--metabolism<br/>Toll-Like Receptor 4--genetics<br/>Transcriptional Activation--drug effects